Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LY2183240 inhibits fatty acid amide hydrolase (FAAH) activity (IC50 = 12.4 nM). LY2183240 is a novel and highly effective blocker of anandamide uptake (IC50 = 270 pM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 39.00 | |
10 mg | In stock | $ 64.00 | |
25 mg | In stock | $ 133.00 | |
50 mg | In stock | $ 253.00 | |
100 mg | In stock | $ 396.00 | |
500 mg | In stock | $ 929.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 43.00 |
Description | LY2183240 inhibits fatty acid amide hydrolase (FAAH) activity (IC50 = 12.4 nM). LY2183240 is a novel and highly effective blocker of anandamide uptake (IC50 = 270 pM). |
Targets&IC50 | FAAH:12.4 nM |
In vitro | LY2183240 increases brain anandamide concentration and exerts antinociceptive effects in the formalin model of pain, anandamide uptake Following i.p. administration in rats. |
Molecular Weight | 307.35 |
Formula | C17H17N5O |
CAS No. | 874902-19-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (162.68 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LY2183240 874902-19-9 Autophagy Metabolism Neuroscience FAAH Inhibitor brain uptake transport hydrolases Fatty acid amide hydrolase LY 2183240 serine LY-2183240 anandamide inhibit inhibitor